Sequence variation in the upstream regulatory region of HPV 18 isolates from cervical cancers

Gynecologic Oncology

Volumn 66, Issue 2, 1997, Pages 282-289

  Rose, Barbara R ^a   Thompson, Carol H ^a   Zhang, Jiawen ^a,c   Stoeter, Michael ^b   Stephen, Amanda ^a   Pfister, Herbert ^b   Tattersall, Martin H N ^a   Cossart, Yvonne E ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF COLOGNE   (Germany)

^c WEST CHINA UNIVERSITY OF MEDICAL SCIENCES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PROTEIN; TRANSCRIPTION FACTOR;

ADULT; AGED; ARTICLE; BINDING SITE; CLINICAL ARTICLE; ELECTROPHORETIC MOBILITY; FEMALE; HUMAN; HUMAN TISSUE; NONHUMAN; OPEN READING FRAME; POINT MUTATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DNA BINDING; TUMOR RECURRENCE; UTERINE CERVIX CANCER; WART VIRUS;

EID: 0031214691     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1997.4740     Document Type: Article

References (38)

1. zur Hausen H. Molecular Pathogenesis of Cancer and the Cervix and Its Causation by Specific Human Papillomavirus Types. Human Pathogenic Papillomaviruses, Current Topics in Microbiology and Immunology. 1994;Springer Verlag, Berlin. p. 131-156.
2. Von Knebel Doeberitz M, Oltersdorf T, Schwartz E, Gissmann L. Correlation of modified human papillomavirus early gene expression with altered growth properties in C4I cervical carcinoma cells. Cancer Res. 48:1988;3780-3766.
3. Werness B A, Levine A J, Howley P M. Association of papillomavirus types 16 and 18 proteins with p53. Science. 248:1990;76-79.
4. Munger K, Werness B A, Dyson N, Phelps W C, Harlow E, Howley P M. Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. J Eur Mol Biol Organ. 8:1989;4099-4105.
5. Hoppe-Seyler F, Butz K. Cellular control of human papillomavirus oncogene transcription. Mol Carcinogen. 10:1994;134-141.
6. Thierry F, Spyrou G, Yaniv M, Howley P. Two AP1 sites binding Jun B are essential for human papillomavirus type 18 transcription in keratinocytes. J Virol. 66:1992;3740-3748.
7. O'Connor M, Bernard H-U. Oct -I activates the epithelial-specific enhancer of human papillomavirus type 16 via a synergistic interaction with NF1 at a conserved composite regulatory element. Virology. 207:1995;77-87.
8. Kurman R J, Schiffman M H, Lancaster W D, Reid R, Jenson A B, Temple G F, Lorincz A T. Analysis of individual HPV types in cervical neoplasia: a possible role for type 18 in rapid progression. Am J Obstet Gynecol. 195:1988;293-296.
9. Walker J, Bloss J D, Liao S-Y, Berman M, Bergen S, Wilczynski S P. Human papillomavirus genotype as a prognostic indicator in carcinoma of the uterine cervix. Obstet Gynecol. 74:1989;781-785.
10. Burnett A F, Barnes W A, Johnson J C, Grenys M D, Willett G D, Barter J F, Doniger J. Prognostic significance of polymerase chain reaction detected human papillomavirus of tumors and lymph nodes in surgically treated stage Ib cervical cancer. Gynecol Oncol. 47:1992;343-347.
11. Rose B R, Thompson C H, Simpson J M, Jarrett C S, Elliott P M, Tattersall M HN, Dalrymple C P, Cossart Y E. Human papillomavirus DNA as a prognostic indicator in early stage cervical cancer: a possible role for type 18. Am J Obstet Gynecol. 173:1995;1461-1468.
12. Romanczuk H, Villa L L, Schlegel R, Howley P. The viral transcriptional regulatory region upstream of the E6 and E7 genes is a major determinant of the differential immortalization activities of HPV types 16 and 18. J Virol. 65:1991;2739-2744.
13. Villa L L, Schlegel R. Differences in transformation activity between HPV 18 and HPV 16 map to the viral LCR-E6-E7 region. Virology. 181:1991;374-377.
14. Ong C K, Chan S H, Campo S M, Fujinaga K, Mavromara-Nazos P, Labropoulou V, Pfister H, Tay S-K, Ter Meulen J, Villa L L, Bernard H-U. Evolution of human papillomavirus type 18: an ancient phylogenetic root in Africa and intratype diversity reflect co-evolution with human ethnic groups. J Virol. 67:1993;6424-6431.
15. Cole S T, Danos O. The nucleotide sequence and genome organisation of human papillomavirus type 18. J Mol Biol. 193:1987;599-608.
16. Swift F W, Bhat H B, Younghusband H B, Hamada H. Characterisation of a cell type specific enhancer found in the human papillomavirus type 18 genome. EMBO J. 6:1987;1339-1344.
17. M, O'Connor, S-Y, Chan, H-U, Bernard, 1995, Transcription factor binding sites in the long control region of genital HPVs, Human Papillomaviruses, Los Alamos National Laboratory, Los Alamos, New Mexico.
18. C, H, Thompson, B, R, Rose, Deleterious effects of formalin acetic acid alcohol (FAA) fixation on the detection of HPV DNA by in situ hybridisation and the polymerase chain reaction, Pathology, 23, 327, 330.
19. Donaldson Y K, Arends M J, Duvall E. PCR analysis of the upstream regulatory region of human papillomavirus genomes in cervical intraepithelial neoplasia and cervical carcinoma. J Clin Pathol. 46:1993;1021-1023.
20. Rose B R, Thompson C H, Chantrill L A, Tattersall M HN, Cossart Y E. Prevalence and distribution of human papillomavirus type 16 DNA in pelvic lymph nodes of patients with cervical cancer and in women with no history of cervical abnormality. Int J Cancer. 53:1992;1-4.
21. Sambrook J, Fritsch E F, Maniatis T. Appendices E1-E7. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. 1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
22. Lis J T. Fractionation of DNA fragments by polyethylene glycol induced precipitation. Methods Enzymol. 65:1980;347-353.
23. Shi Y, Seto E, Chang L S, Shenk T. Transcriptional repression by YY1, a human GL1-Kruppel-related protein, and relief of repression by adenovirus E1A protein. Cell. 67:1991;377-388.
24. Bosch F X, Manos M, Munoz N, Sherman M, Jansen A M, Peto J. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst. 87:1995;796-802.
25. Higgins G D, Davy M, Roder D, Uzelin D M, Philips G E, Burrell C J. Increased age and mortality associated with cervical cancers negative for human papillomavirus RNA. Lancet. 338:1991;910-913.
26. van Bommel P FJ, van den Brule A JC, Helmerhorst T JM, Gallee M PW, Gaarenstroom K N, Walboomers J MM. HPV DNA Presence and HPV genotypes as prognostic factors in low-stage squamous cell cervical cancer. Gynecol Oncol. 48:1993;333-337.
27. Chen T M, Chen C A, Wu C C, Huang S C, Chang C F, Hsieh C Y. The genotypes and prognostic significance of human papillomaviruses in cervical cancer. Int J Cancer. 57:1994;181-184.
28. Chan S-Y, Bernard H-U, Ong C-K, Chan S-P, Hofman B, Delius H. Molecular variants of human papillomavirus type 16 from four continents suggest ancient pandemic spread of the virus and its coevolution with humankind. J Virol. 66:1992;2057-2066.
29. Chow L T, Broker T R. Papillomavirus replication. Intervirology. 37:1994;159-167.
30. Rando R F, Geoff D E, Chirikjian J G, Lancaster W D. Isolation and characterisation of a novel human papillomavirus type 6 DNA from an invasive vulvar carcinoma. J Virol. 57:1986;353-356.
31. Bercovich J A, Centeno C R, Aguilar o G, Grinstein G, Kahn T. Presence and integration of human papillomavirus type 6 in a tonsillar carcinoma. J Gen Virol. 72:1991;2569-2572.
32. Byrne J C, Tsao M-S, Fraser R S, Howley P M. Human papillomavirus-11 DNA in a patient with chronic laryng-tracheobronchial papillomatosis and metastatic squamous-cell carcinoma of the lung. N Engl J Med. 317:1991;873-878.
33. DiLorenzo T P, Tamson A, Abramson A L, Steinberg B M. Human papillomavirus type 6a DNA in the lung carcinoma of a patient with recurrent laryngeal papillomatosis is characterised by a partial duplication. J Gen Virol. 73:1992;423-428.
34. Dong X-P, Stubenrauch F, Beyer-Finkler E, Pfister H. Prevalence of deletions of YY1-binding sites in episomal HPV 16 DNA from cervical cancers. Int J Cancer. 58:1994;803-808.
35. May M, Dong X P, Beyer-Finkler E, Stubenrauch F, Fuchs P, Pfister H. The E6/E7 promoter of extrachromosomal HPV 16 DNA in cervical cancers escapes from cellular repression by mutation of target sequences for YY1. EMBO J. 13:1994;1460-1466.
36. Bernard H-U, Apt D. Transcriptional control and cell type specificity of HPV gene expression. Arch Dermatol. 130:1994;210-214.
37. Heinzel P A, Chan S-H, Ho L, O'Connor M, Balaram P, Campo M S, Fujinaga K, Kiviat N, Kuypers J, Pfister H, Steinberg B M, Tay S-K, Villa L L, Bernard H-U. Variation of human papillomavirus type 6 (HPV6) and HPV 11 genomes sampled throughout the world. J Clin Microbiol. 33:1995;1746-1754.
38. Usheva A, Shenk T. TATA-binding protein-independent initiation: YY1, TFIIB, and RNA polymerase II direct basal transcription on supercoiled template DNA. Cell. 76:1994;1115-1121.